홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Morpholine → 2-(2-Cyclopropylpyrimidin-5-yl)-2-morpholinoethanamine

HRID 1481356
인쇄

반응식

HRID 1481356 반응식
FC1(F)[CH2:7][CH2:6][N:5]([CH:8]([C:11]2[CH:16]=CC(C(F)(F)F)=C[CH:12]=2)[CH2:9][NH2:10])[CH2:4][CH2:3]1.[CH:22]1([C:25]2[N:30]=CC(C=O)=C[N:26]=2)[CH2:24][CH2:23]1.N1CC[O:36]CC1>>[CH:22]1([C:25]2[N:30]=[CH:12][C:11]([CH:8]([N:5]3[CH2:4][CH2:3][O:36][CH2:7][CH2:6]3)[CH2:9][NH2:10])=[CH:16][N:26]=2)[CH2:24][CH2:23]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 8083MorpholineHCID 249036232-Cyclopropylpyrimidine-5-carbaldehydeHCID 897046912-(4,4-Difluoropiperidin-1-yl)-2-(4-(trifluoromethyl)phenyl)-ethanamine

생성물 1

HCID 897047072-(2-Cyclopropylpyrimidin-5-yl)-2-morpholinoethanamine

실험 절차

This compound was prepared using a method analogous to that of 2-(4,4-difluoropiperidin-1-yl)-2-(4-(trifluoromethyl)phenyl)-ethanamine (A.2.18), 2-cyclopropylpyrimidine-5-carbaldehyde replacing 4-(trifluoromethyl)benzaldehyde and morpholine replacing 4,4-difluoropiperidine HCl.

후처리

  1. customThis compound was prepared

출처 및 근거

ORD 기록
ord-2a8d99e46ef64b2786a02d1b470293a6
출처 데이터셋
uspto-grants-2016_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09409917B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트